CASP3 and cerebral infarction: Tang et al. found that EA treatment could downregulate the activation of cleaved caspase-3, reduce neuronal apoptosis, and dramatically reduce neurological impairment and the volume of cerebral infarcts in rats with ischemic stroke [22].